Why did Gubra stock fall on 8 October?
Written after the close on
Gubra −4.11%
Gubra fell sharply in the last session. Over the last five trading days Gubra fell clearly while the OMX Copenhagen 25 was roughly unchanged, so it moved against the market. That positive news likely did not offset broader pressure on healthcare and biotech shares, which often move on interest-rate expectations and risk appetite rather than company-specific events. Watch whether the Phase 2 trial of ABBV-295, started in August, produces further updates.